Day Wesley 4
4 · VIVUS INC · Filed Feb 24, 2012
Insider Transaction Report
Form 4
VIVUS INCVVUS
Day Wesley
VP, Clinical Research
Transactions
- Exercise/Conversion
Common Stock
2012-02-23$3.28/sh+9,958$32,662→ 26,758 total - Exercise/Conversion
Common Stock
2012-02-23$4.25/sh+19,738$83,887→ 36,538 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-02-23−50,262→ 0 totalExercise: $4.25Exp: 2017-01-29→ Common Stock (50,262 underlying) - Sale
Common Stock
2012-02-23$20.69/sh−19,738$408,379→ 16,800 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-02-23−19,738→ 0 totalExercise: $4.25Exp: 2017-01-29→ Common Stock (19,738 underlying) - Sale
Common Stock
2012-02-23$20.69/sh−9,958$206,031→ 16,800 total - Exercise/Conversion
Common Stock
2012-02-23$4.25/sh+50,262$213,614→ 67,062 total - Sale
Common Stock
2012-02-23$20.69/sh−50,262$1,039,921→ 16,800 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-02-23−9,958→ 0 totalExercise: $3.28Exp: 2016-05-09→ Common Stock (9,958 underlying)
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2011.
- [F2]The option is fully vested and immediately exercisable.